MRI Safety Screening in a Patient with a Cardiac Pacemaker
A 72-year-old woman with a history of breast cancer is referred for MRI simulation for radiation therapy to the left breast. She has a cardiac pacemaker implanted 5 years ago. The pacemaker is a Medtronic Advisa MRI SureScan, which is MRI conditional. The patient weighs 85 kg and has claustrophobia. The MRI department has a 1.5 T Siemens Aera and a 3 T Siemens Skyra. The radiation oncologist wants to use MRI for treatment planning because the patient has dense breast tissue and the tumor is not well visualized on CT. The patient's pacemaker was implanted at a hospital that is not the same as the current one, and the patient does not have the pacemaker identification card. The MRI technologist is concerned about safety.
1. What are the key safety considerations for performing MRI in this patient, and how would you determine if it is safe?
Read the worked answer
Key safety considerations for MRI in a patient with a cardiac pacemaker include: 1) The pacemaker must be MRI conditional, meaning it is designed to be safe under specific conditions. The Medtronic Advisa MRI SureScan is MRI conditional, but only under certain conditions: static field strength (1.5 T or 3 T? Actually, the Advisa MRI SureScan is approved for 1.5 T only, I think. Need to verify: Medtronic Advisa MRI SureScan is approved for 1.5 T. Some newer ones are 3 T. So we must confirm the specific model and its conditions. 2) The patient must have the device identification card or we must obtain records from the implanting hospital to confirm the exact model and leads. 3) The leads must also be MRI conditional; the Advisa system uses specific leads (e.g., Medtronic 5086MRI). 4) The patient must be screened for any other implants or foreign bodies. 5) The MRI must be performed under specific conditions: limited SAR, specific coil types, and monitoring. 6) A trained cardiologist or electrophysiologist should be present or on call. 7) The patient's pacemaker should be reprogrammed to an MRI-safe mode before the scan, and back after. 8) Informed consent. 9) Monitoring of ECG, blood pressure, and pulse oximetry during the scan. 10) The patient has claustrophobia, which may require sedation, but that adds risk. 11) The patient's weight (85 kg) may affect SAR limits. To determine safety, we must: obtain the device model and leads information from the implanting hospital or the patient's records; confirm that the device and leads are MRI conditional and that the conditions can be met (e.g., 1.5 T only, max SAR, etc.); ensure that the MRI scanner is on the approved list (Siemens Aera 1.5 T is likely approved, but check); have a safety checklist; and have a plan for emergency. Without the ID card, we cannot proceed until we verify the device. We could contact Medtronic with the patient's information to identify the device, but that may take time. Alternatively, we could use CT simulation only, but the radiation oncologist wants MRI. The safest approach is to postpone MRI until device verification, and if not possible, use CT.
2. What are the specific conditions for scanning a patient with an MRI-conditional pacemaker, and how would you ensure they are met?
Read the worked answer
Specific conditions for scanning a patient with an MRI-conditional pacemaker (e.g., Medtronic Advisa MRI SureScan) typically include: 1) Static magnetic field strength: 1.5 T only (for Advisa). 2) Maximum spatial gradient: specified (e.g., 20 T/m). 3) Maximum slew rate: specified (e.g., 200 T/m/s per axis). 4) Radiofrequency: only transmit/receive coils that are approved (e.g., body coil for transmission, receive-only coils). 5) Specific absorption rate (SAR): limited to 2 W/kg for whole body, or 3.2 W/kg for head? Actually, for pacemakers, often 2 W/kg whole body. 6) Scan duration: limited to 30 minutes? Some devices have time limits. 7) The pacemaker must be programmed to MRI mode (asynchronous pacing or off) before the scan. 8) Monitoring: ECG, pulse oximetry, and voice contact. 9) A qualified person (cardiologist) must be present. 10) The patient must be positioned so that the isocenter is above the pacemaker? Actually, for some devices, the isocenter must be at least 10 cm from the device? No, that's for older devices. For MRI conditional, the device can be in the field but must be within the approved conditions. To ensure they are met: verify the scanner is 1.5 T (use the Aera, not the Skyra 3T); check that the coils used are approved (e.g., body coil for transmission, and a receive-only breast coil); set SAR limits in the scanner software to the device's limit; program the pacemaker to MRI mode with a programmer; have a cardiologist present; monitor the patient; and limit scan time. Also, ensure the patient's weight is considered for SAR calculations. Document all steps.
3. If the pacemaker cannot be confirmed as MRI conditional, what alternatives would you propose for treatment planning?
Read the worked answer
If the pacemaker cannot be confirmed as MRI conditional, MRI is contraindicated. Alternatives for treatment planning include: 1) CT simulation with contrast if renal function allows, to better visualize the tumor. However, the patient has dense breast tissue, so CT may still be suboptimal. 2) Ultrasound for target delineation? Not typically used for breast radiotherapy planning, but could help in some cases. 3) PET/CT with FDG or other tracers? Not standard for breast cancer planning. 4) Use of a different imaging modality like dedicated breast MRI? But that still requires MRI, which is contraindicated. 5) Consider removing the pacemaker and replacing with an MRI-conditional one, but that is invasive and may delay treatment. 6) Use of a 0.3T open MRI? Lower field might be safer for non-conditional devices, but still not recommended without verification. 7) Surgical clips and surgical bed can be visualized on CT; the radiation oncologist can use clinical information and CT to define the target, accepting larger margins. 8) Use of fiducial markers placed under ultrasound guidance before CT simulation to help localize the tumor bed. 9) If the patient has a lumpectomy, the cavity may be visible on CT with surgical clips. The best approach is to discuss with the radiation oncologist and weigh the risks of MRI versus the benefits. If MRI is essential, consider device replacement. Otherwise, proceed with CT-based planning with careful clinical correlation.